REQUEST A DEMO
Total
USD $0.00
Search more companies

Iqvia Rds East Asia Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Iqvia Rds East Asia Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

IQVIA RDS East Asia Pte. Ltd. is a Singapore-based regional entity of IQVIA Holdings Inc., a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The company supports clinical trial management, research and development services, data analytics and regulatory support across East Asia markets. IQVIA's offerings serve pharmaceutical, biotechnology and medical device companies, supporting drug development and commercialisation. Through its Singapore operations, the company strengthens regional coordination and life sciences innovation capabilities.

Headquarters
79 Anson Road #19-01 Singapore
Singapore; Singapore; Postal Code: 079906

Contact Details: Purchase the Iqvia Rds East Asia Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Iqvia Rds East Asia Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Iqvia Rds East Asia Pte. Ltd. report to view the information.
Incorporation Date:
March 21, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Iqvia Rds East Asia Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
314.98%
Total operating revenue
314.98%
Net Profit (Loss) for the Period
35.05%
Total Assets
57.37%
Total Equity
150.74%
Net Profit Margin
-54.04%
Return on Equity (ROE)
-51.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?